Breaking News

Newly Merged AAI-CML Names CFO

December 3, 2013

Evans brings 25 years of financial leadership experience

Eric Evans has been appointed chief financial officer of the newly merged companies, AAIPharma Services and Cambridge Major Laboratories (AAI-CML). Mr. Evans brings more than 25 years of financial leadership experience. Most recently, he served as chief financial officer of AAIPharma Services, and prior to that, he was chief financial officer and executive vice president of Patheon, Inc., and vice president and controller for Novartis Pharmaceuticals. He also served as chief financial officer for the U.S. division of Sandoz.
 
“Eric’s extensive financial experience in both the pharmaceutical and contract services sectors and his ability to work in a client-centered business structure make him a natural fit as chief financial officer of the merged company,” said Patrick Walsh, chief executive officer of AAI-CML. “He brings leadership and experience managing contract development and manufacturing organizations through scalable growth.”
blog comments powered by Disqus
  • Staying Ahead in the Small Molecule Space

    Staying Ahead in the Small Molecule Space

    Dr. Matthew Moorcroft, VP Global Marketing, Cambrex||September 8, 2016
    Understand what is happening in the market and react accordingly

  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments

  • Patent Law  and Contract Manufacturing

    Patent Law and Contract Manufacturing

    Beverly W. Lubit, Member of the Firm, Chiesa Shahinian & Giantomasi||September 8, 2016
    Analyzing the impact of The Medicines Co. vs. Hospira Inc. decision